3/6/26 16:05 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,U.S. | M.d | 0 | 0.00 | 0 | 20 | 38 | 75 | D | | | | | | | | | | | | | | |
3/6/26 16:05 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,U.S. | S.d | -295 | 32.46 | 0 | -9 | -11 | 75 | D | | | | | | | | | | | | | | |
11/24/25 16:03 | 11/20/25 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,Head | M.d | 0 | 0.00 | 0 | 63 | 999% | 64 | D | | | | | | | | | | | | | | |
11/24/25 16:03 | 11/20/25 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,Head | S.d | -700 | 24.78 | 0 | -28 | -31 | 64 | D | | | | | | | | | | | | | | |
11/18/25 16:01 | 11/14/25 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,Head | S | -753 | 25.11 | 0 | -30 | -51 | 28 | D | | | | | | | | | | | | | | |
3/6/25 16:19 | 3/4/25 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,Head | M.d | 0 | 0.00 | 0 | 20 | 54 | 58 | D | | | | | | | | | | | | | | |
3/6/25 16:19 | 3/4/25 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,Head | S.dm | -98 | 15.80 | 0 | -6 | -10 | 58 | D | | | | | | | | | | | | | | |
11/21/24 16:04 | 11/20/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,Head | M.d | 0 | 0.00 | 0 | 63 | | 44 | D | | | | | | | | | | | | | | |
11/21/24 16:04 | 11/20/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,Head | S.d | -327 | 16.87 | 0 | -19 | -31 | 44 | D | | | | | | | | | | | | | | |